$129.56
+4.19
(+3.34%)
As of Jul 4, 2026, 11:47 PM EDT
Merck & Co. (MRK) is trading up at $129.56 (+3.34%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
About Merck & Co.
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
Recent News (20)
-
Responsive Playbooks and the MRK Inflection Responsive Playbooks and the MRK Inflection Stock Traders Daily
-
Redwood Grove Capital, LLC's Merck & Co Inc(MRK) Holding History Redwood Grove Capital, LLC's Merck & Co Inc(MRK) Holding History GuruFocus
-
Merck (MRK) Stock Trades At A Discount To Cash Flow But A Premium To Earnings Merck (MRK) Stock Trades At A Discount To Cash Flow But A Premium To Earnings simplywall.st
-
Merck (MRK) Stock Trades At A Discount To Cash Flow But A Premium To Earnings Merck (MRK) Stock Trades At A Discount To Cash Flow But A Premium To Earnings simplywall.st
-
Merck KGaA (XTRA:MRK) Expands Into Precision Cardiology, Is The Upside Already Priced In? Merck KGaA (XTRA:MRK) Expands Into Precision Cardiology, Is The Upside Already Priced In? simplywall.st
-
-
-
-
-
-
Merck's Post-Keytruda Playbook Is Working, But Valuation Has Caught Up (NYSE:MRK) Merck's Post-Keytruda Playbook Is Working, But Valuation Has Caught Up (NYSE:MRK) Seeking Alpha
-
-
-
-
-
-
-
-
-